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Abstract
Behcet’s disease (BD) is a polysymptomatic and recurrent systemic vasculitis with a 
chronic course and unknown cause. Joint involvement in BD is common. Arthritis and 
arthralgia in BD are known to be the most common rheumatologic findings. Arthropathy 
in BD is monoarthritis or asymmetrical oligoarthritis affecting larger joints, and it is usu-
ally acute or recurrent with a self-limiting course. Bone deformity and destruction are 
rare. Autoantibodies are typically negative, and the presence of anti-CCP antibodies at 
high titers favors a diagnosis of rheumatoid arthritis (RA). Although joint involvement is 
clinically well recognized, few histologic studies have been reported. In this chapter, we 
focused on the synovitis and synovial histopathology in BD.
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1. Introduction
Behcet’s disease (BD) is a polysymptomatic and recurrent systemic vasculitis with a chronic 
course and unknown cause [1]. Joint involvement in BD is very common. Arthropathy in BD 
is monoarthritis or asymmetrical oligoarthritis, and it is usually acute or recurrent [2, 3]. In 
addition, arthritis associated with BD is usually self-limiting and non-deforming; bone erosive 
change of joints is extremely rare [4]. It typically affects larger joints (knees, ankles, wrists, and 
elbows). Unusual findings include arthritis with deformities and/or destruction. The synovial 
histopathology shows a wide range of features, including lining cell hyperplasia, angiogen-
esis, granulation tissue, and lymphoid follicle formation. Usually, autoantibodies are typi-
cally negative, and the presence of anti-CCP antibodies at high titers favors a diagnosis of RA. 
First-line treatment includes non-steroidal anti-inflammatory drugs, or corticosteroids for 
severe cases, whereas colchicine has shown some efficacy for the treatment of recurrent and 
refractory arthritis. Although joint involvement is clinically well recognized, few histologic 
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studies have been reported. We review joint involvement in BD patients with both typical and 
atypical findings. In this chapter, we focused on the synovitis and synovial histopathology in 
BD. In addition, we introduce rare cases, and we have encountered with synovial findings.
1.1. Typical joint involvement
Joint manifestations are very common, being present in 40–75% of BD patients. According to a 
retrospective review of 340 cases, joint involvement is the initial manifestation of BD in 18.2% 
[5]. The knees, ankles, wrists, and elbows are frequently affected, while the involvement of 
small joints in the hands and feet is less common. Most cases demonstrate monoarthritis or 
oligoarthritis and usually run an acute or recurrent course [2]. Polyartritis and the chronic 
form are rare. In addition, arthritis associated with BD is usually benign, self-limiting, and 
non-deforming. Bone erosive change of the joints is extremely rare [4]. Joint deformities and 
destruction have been reported in only a few cases [6].
According to another retrospective review of 176 cases [7], rheumatic manifestations were 
noted in 45%. Articular manifestations were the initial disease manifestation in 16.5%. 
Inflammatory arthralgia was observed in 81% mainly in the large lower limb joints. Arthritis 
was less common: oligoarthritis, 7.5%; monoarthritis, 6.5%; and polyarthritis, 5%. The disease 
course was acute in most patients. Axial involvement was noted: spinal pain in 2.9%, isolated 
sacroiliitis in 7.5%, and definite ankylosing spondylitis in 5%.
Frikha et al. [8] reviewed the medical records of 553 BD patients. Rheumatologic manifestations 
were observed in 71.1%, being second after cutaneo-mucosal involvement. Rheumatologic 
manifestations in BD are defined as inflammatory arthralgia, peripheral arthritis, intermit-
tent hydrarthrosis, popliteal cysts, and spondylarthropathy (low back pain with sacroiliitis). 
Definite arthritis was noted in 50%. The most frequent manifestation is a non-erosive and 
non-deforming monoarthritis or asymmetrical oligoarthritis, commonly subacute and self-
limiting, typically affecting the larger joints.
1.2. Hand involvement
In a recent randomized study in Turkey, clinical hand involvement was investigated in 57 BD 
patients [9], and the prevalence of hand involvement in BD was found to be relatively high. 
Thus, terminal phalangeal pulp resorption was observed in 29.8%, which might be induced 
by the vasculitic process due to repeated digital infarcts. Rheumatoid-like hand findings 
were noted in 28.1%, dorsal interosseous atrophy was observed in 20.1%, and erythema 
of the digitis was identified in 20%. Twenty-four patients (42.1%) showed scintigraphic 
abnormalities.
1.3. Atypical joint involvement: erosive changes
Erosive changes due to joint involvement by BD are also infrequent. Thus, Vernon-Roberts 
et al. [6] reported that two of six patients with BD showed radiologically erosive changes in 
the hip and manubriosternal joints. Armas et al. [10] reported radiologically well-defined 
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“ punched-out” erosive arthropathy in the head of the first metacarpophalangeal (MCP) joints. 
Düzgün and Ateş [11] reviewed erosive arthropathy in BD patients with references to 11 
papers. Erosive changes were reported in axial joints (sacroiliac) and peripheral joints such 
as intertarsal and MTP (metatarsophalangeal) joints of the foot, intercarpal and MCP joints 
of the hand, knee, wrist, and hip joints [2, 4–6, 10–13]. Enthesis was also noted in calcaneal 
joints. More recently, Aydin et al. [14] reported an unusual case of BD with extensive erosive 
arthropathy radiologically mimicking psoriatic arthritis. In their case, erosive changes at the 
styloid process of the left ulnar bone were notable. Yurdaku et al. reported five out of 47 BD 
patients who had radiologically erosive lesions in a prospective study [2]. We also reported [15] 
a female patient with BD who demonstrated arthritis in the sternocostal joint showing erosive 
changes, which rarely occur in BD [16]. Taken together, erosive change can be found in various 
joints, although it is an atypical change in BD.
1.4. Atypical joint involvement: destructive arthritis
In the review of 553 BD patients by Frikha et al., as mentioned above, only eight patients 
(1.4% overall, 2% of patients with rheumatic involvement) had destructive arthritis (defined 
by radiological changes: erosions and/or geodes and/or global narrowing of the joint space 
and/or ankylosis) [8]. The involved joints included knee joints, sternoclavicular joints, the 
wrist, foot, and tarsal scaphoid, whereas the spine or sacroiliac joint was not affected. On the 
other hand, sacroiliitis and enthesitis have been reported in BD, although their prevalence is 
low [17, 18].
1.5. Synovial histology
It has been reported that approximately 40–50% of patients with BD have synovitis [2, 19], 
although there have been a limited number of reports on the synovial histology in BD [2, 
6, 20]. Yuradakul et al. reported the findings of synovial biopsy in 12 patients, revealing 
superficial ulceration, paucity of plasma cells, and, in five instances, lymphoid follicle for-
mation [2]. Vernon-Roberts et al. indicated that only superficial zones of the synovial tissue 
were affected. In seven of eight specimens, the superficial zones were replaced by densely 
inflamed granulation tissue composed of lymphocytes mixed with macrophages, vascular 
elements, fibroblasts, and neutrophils [6]. Gibson et al. [20] noted that synovial changes in BD 
are similar to those observed in early RA, and demonstrated hypertrophy and hyperplasia of 
synovial lining cells, hypervascularity, subsynovial accumulation of inflammatory cells, and 
replacement of superficial zones of the synovial membrane by densely inflamed granulation 
tissue. However, immunofluorescent studies indicated that the consistent deposition of IgG 
might be characteristic of BD [20]. Moll et al. [21] described the macroscopic features of early 
untreated knee synovitis in BD and psoriatic arthritis (PsA). They reported the presence of 
extensive fibrinoid membranes and large areas of erythematous synovitis without villi or 
a distinctive vascular pattern in early and untreated BD. Cañete et al. [22] noted that poly-
morph nuclear neutrophils and lymphocytes were indicators of cytotoxic molecules in early 
untreated synovitis in BD. Thus, the histopathological characteristics of synovial tissue in BD 
may be diverse.
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1.6. Presentation of synovial histology in our cases
We previously reported the synovial histology and destructive joint manifestations in three 
BD patients who underwent orthopedic surgery [23]. They all had morning stiffness. The joints 
affected in these cases were the ankle, wrist, elbow, and knee. Case 1 presented bleeding from 
ulcers of the small intestine and complained of polyarthritis (both ankles, wrists, and PIP joints) 
and severe recurrent pain in the left ankle and intermittent claudication. The patient was diag-
nosed as having BD (incomplete type) was with oral prednisolone (15 mg/day). Radiographs of the 
left ankle revealed a sclerotic joint space and osteoporotic change, for which arthrodesis was 
performed. Histological studies of synovial tissues revealed non-specific chronic synovitis 
and the infiltration of lymphoid cells around the vascular cells with fibrinoid changes. There 
was no sign of vasculitis.
Case 2 underwent Darrach’s procedure for the right wrist joint. Histological findings showed 
neither the formation of lymphoid follicle formation nor infiltration of plasma cells, although 
some neutrophils and lymphocytes were detected. She had the chronic form of polyarthritis 
of the right wrist and elbow, left knee, both ankles, and PIP joints and received synovectomy. 
She had been treated with NSAIDs for arthritis. Radiographs revealed joint space narrowing in 
the right elbow and left knee. Synovial tissue from the elbow showed hyperplasia of the syno-
vial lining cells and the infiltration of plasma cells, with the formation of numerous lymphoid 
follicles. Synovial tissue from the knee showed hyperplasia of the synovial lining cells, and 
the perivascular infiltration of lymphoid cells.
Case 3 had chronic arthritis on left knee, both wrists and PIP joints, and radiography revealed 
bone atrophy and ankylosis of the left knee, erosive changes of the PIP joints, and destructive 
changes of the wrists, mimicking rheumatoid arthritis. Synovectomy was then performed, 
and histopathological findings showed hyperplasia of the lining cells, the deposition of fibrin, 
infiltration of inflammatory cells, and marked vascularity. These features cannot be differenti-
ated from those of rheumatoid arthritis.
1.7. Synovial immunopathology in BD
Cañete et al. [22] investigated the differences in synovial immunopathology between early 
active and untreated BD and PsA. There was marked CD15+neutrophilic inflammation in the 
intimal lining layer in BD synovitis. This increased number of polymorphonuclear neutrophils 
(PMNs) has been reported not only in the synovium but also in the skin and central nervous 
system. As for lymphocytes, CD3+T cells, but neither CD20+ B cells nor CD138+ plasma cells, 
were increased in BD [22]. Specific T-cell subsets are associated with sterile neutrophil-rich 
inflammation as observed in BD synovitis, and this may explain the simultaneous increase 
of both T cells and PMN [24]. The analysis of the T-cell population in SF showed that there 
was no clear shift in the CD4/CD8 ratio or Th1/Th2/Th17 profile. The synovial fluid levels 
of perforin, an effector molecule of cytotoxic cells, showed a significant increase in BD [22]. 
This suggests the relevance of cytotoxicity in BD synovitis [25, 26]. Suh et al. [27] reported 
that antigen-driven clonal B-cell proliferation occurs in the synovium in BD. They identified 
immunoglobulin transcripts clonally expanded in the synovium in BD.
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1.8. Humoral protective factors in synovial fluid or blood
As with BD, the pathogenesis of arthritis and protective mechanisms against erosive changes 
needs to be elucidated. The plasminogen activation system can contribute to the pathogenesis 
of destructive joint disease. Ertenli et al. [28] demonstrated that synovial fluid (SF) in BD is 
inflammatory in nature. They reported increased SF IL-1β levels in BD patients. In SF, levels 
of IL-1β, IL-1ra, and TGF-β were higher in BD than osteoarthritis (OA) [28]. Thus, they specu-
lated that IL1ra and TGF-β might serve as protective factors against cartilage destruction. Pay 
et al. [29] also reported that BD and RA patients had higher synovial IL-1β than OA patients. 
MMP-3 and proinflammatory cytokines except IL-1β were expressed in small quantities in 
BD synovitis; this may explain the non-erosive character of BD arthritis. Thus, IL-β may be 
involved in the pathogenesis of BD synovitis. In addition, relatively lower levels of IL-18 
in the SF of BD patients might be the cause of less marked inflammation in BD arthritis. 
Recently, Karasneh et al. [30] reported that IL-1 gene cluster polymorphisms, including the 
IL-1B gene, are associated with an increased risk of BD. Therefore, the detection of increased 
synovial IL-1β levels in BD patients could be determined genetically by functional polymor-
phism, leading to differential gene regulation and expression.
Ozturk et al. [31] reported that systemic bloodstream and local SF plasminogen activator 
inhibitor-1 (PAI-1) antigen levels and PAI-1 activities were higher in BD patients than RA 
patients and healthy controls. PAI-1 may promote hypofibrinolysis of BD vasculopathy and 
also plays a protective role against arthritis in BD patients. They speculated that elevated 
PAI-1 antigen and activities in the synovial fluid of BD patients contribute to the unique 
nonerosive character of BD.
1.9. Proinflammatory factors in synovial fluid or blood
Aktas Cetin et al. [32] reported that in peripheral blood mononuclear cells (PBMCs), CD4, CD25, 
HLA-DR expression and intracellular IL-12, and TNF-αlevels of CD3+ T cells were increased 
in BD compared with HC. Compared with AS patients, CD25, HLA-DR surface expression, 
and intracellular IFN-γ and TNF-αlevels in T cells were elevated in BD. Th1 polarization 
occurred in both the peripheral blood and SF of BD patients with  arthritis. Duygulu et al. [33] 
demonstrated that the levels of both serum and erythrocyte nitric oxide (NO), the most abun-
dant free radial in the body, were elevated in BD patients and associated with disease activ-
ity. In addition, synovial NO levels were positively correlated with serum levels. Turan et al. 
[34] analyzed the production of soluble TNF receptors, sTNFR1 and sTNFR2, in BD patients. 
STNFR2 plasma concentrations are closely linked with active BD and especially with arthritis. 
The expression of TNFR molecules in mast cells of mucocutaneous lesions indicates the fun-
damental role of the TNF/TNFR pathway in BD.
Erdem et al. [35] demonstrated that the expression of CXC chemokines, including IL-8, GRO-a, 
and ENA-78, was lower in the SF of patients with BD than in those with RA. All CXC chemo-
kines and VEGF were induced by IL-18, which are involved in angiogenesis and the devel-
opment of pannus. Thus, the lower levels of these chemokines in the SF of BD patients may 
explain the lack of pannus formation or erosion in BD arthritis.
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Ertenli et al. [28] reported higher levels of synovial IL-8 in BD than OA patients. They suggested 
that elevated synovial IL-8 might play a pivotal role in the process of neutrophil migration in 
BD synovitis and reflect a nonspecific inflammatory process. Erdem et al. [35] speculated that 
synovial IL-8 levels increased via the attraction of more neutrophils to SF, and this, in addi-
tion to its angiogenic properties, might be responsible for the development of acute synovitis.
1.10. Metabolomic evaluation of BD in synovial fluid: potential biomarkers
Ahn et al. [36] investigated possible metabolic patterns and potential biomarkers of BD with 
arthritis on metabolic profiling of SF from BD patients with arthritis and seronegative arthri-
tis (SNA). They identified 123 metabolites. Compared with SNA, BD patients with arthritis 
exhibited relatively high levels of glutamate, valine, citramalate, leucine, methionine sulfox-
ide, glycerate, phosphate, lysine, isoleucine, urea, and citrulline. Finally, they identified two 
markers, elevated methionine sulfoxide and citrulline, associated with increased oxidative 
stress, providing a potential link to BD-associated neutrophil hyperactivity. Gultamate, citra-
malate, and valine were selected as putative biomarkers for BD with arthritis.
1.11. Anti-cyclic citrullinated peptide (Anti-CCP) antibodies and BD
Anti-CCP antibodies are a more reliable diagnostic marker for RA and closely associated with 
the prognosis in RA patients [37]. Recently, a significant correlation was reported between 
anti-CCP antibodies and joint symptoms in patients with familial Mediterranean fever [38]. In 
a study of 189 Korean BD patients, only seven patients (3.7%) were positive for anti-CCP anti-
bodies, five of which (71.4%) had polyarticular joint involvement, and the other two (28.6%) 
had oligoarticular involvement. Among the seven patients, one patient with an anti-CCP anti-
body titer of over 100 U/mL fulfilled the diagnostic criteria for both BD and RA. Of course, all 
BD patients without articular involvement were negative on an anti-CCP antibody test [39]. 
Since it has been demonstrated that anti-CCP antibodies are elevated prior to the develop-
ment of RA, we need to be careful when diagnosing BD patients who show arthritis in the 
presence of positive anti-CCP antibodies.
1.12. Sonographic study
Ultrasound (US) evaluation is useful for the detection of joint involvement. Synovial prolif-
eration, joint effusion, and bone surface erosions are detectable, and even asymptomatic joint 
involvement showed US alterations [40]. Ceccarelli et al. performed knee United States in 30 
BD patients and found that 60% of patients showed knee involvement based on United States. 
They detected synovial proliferation in 14%, joint effusion in 46%, and bone surface erosions 
in 10% of patients. They also pointed out that subjects with a higher US score showed a posi-
tive correlation with disease activities such as acneiform skin lesions. Gok et al. performed 
high-frequency United States and power Doppler ultrasonography (PDUS) examination of 
knee joints [41]. By ultrasonography, synovial hypertrophy scores were lower in patients 
with BD than in those with RA and spondyloarthropahy. However, no difference was found 
between BD, RA, and spondyloarthropahy patients based on PD signal scores using PDUS. 
Gok et al. also investigated ultrasonographic findings and synovial angiogenesis modulators. 
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Cumulative effusion scores were positively correlated with angiopoietin-1, angiostatin, and 
basic fibroblast growth factor (bFGF), while they were negatively correlated with thrombo-
spondin-1 levels. Synovial hypertrophy scores were positively correlated with angiostatin 
and bFGF levels and negatively correlated with thrombospondin-1. No correlation was found 
between PD scores and modulators of angiogenesis.
1.13. Magnetic resonance imaging study and Tc-99m-MDP bone scintigraphy
Magnetic resonance imaging has been reported to be sensitive for detecting early arthritis of 
BD. Choi et al. showed syovial thickening and effusion based on a high signal intensity on 
T2-weighted images of two BD patients with arthropathy [42].
Sugawara et al. reported radiography and magnetic resonance imaging of hand and wrist 
arthritis in four BD patients [43]. They concluded that characteristics on imaging of arthritis 
in BD patients vary and may be similar to those of psoriatic arthritis patients. Erosion in the 
distal interphalangeal joint was seen, but the type of erosion was of the gull-wing type, being 
different from RA variants.
Joint scanning with 99m Tc is a more valuable tool for the prediction of hand joint inflamma-
tion than radiography [44]. Bone scintigraphy is also more sensitive for the earlier diagnosis 
of joint involvement, especially in sacroileal joints [45].
2. Conclusion
In summary, arthritis and arthralgia are common in BD patients, and joint manifestations 
of BD patients are diverse: sometimes mimicking rheumatoid arthritis, PsA, and spodyloar-
thritides radiologically. In addition, the histopathological characteristics of synovial tissue in 
BD may be various.
Thus, despite the rarity of destructive arthropathies, this unusual form should be known and 
considered in the differential diagnosis of other rheumatic diseases.
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